Literature DB >> 9688437

Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension.

K Kulan1, D Ural, B Komsuoğlu, A Ağaçdiken, O Göldeli, S S Komsuoğlu.   

Abstract

The present study was designed to detect the arrhythmogenic effect of left ventricular hypertrophy, QTc prolongation and the relationship between the QTc duration and ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension. Sixty-eight hypertensive patients (51 male and 17 female, mean age 52+/-6 years) and 30 healthy normotensive subjects (22 male and eight female, mean age 49+/-6 years) were enrolled in the study. The frequency of ventricular arrhythmias was investigated with 24-h ambulatory electrocardiographic monitoring and grade 3 and 4 ventricular arrhythmias according to a modified Lown and Wolf classification were accepted as complex arrhythmias. The echocardiographic features of the patients were divided into five groups as follows: (1) normal left ventricular diameter and wall thickness, (2) concentric left ventricular hypertrophy, (3) asymmetric septal hypertrophy, (4) dilated left ventricle, (5) dilated and hypertrophic left ventricle. The frequency of complex ventricular ectopia and the QTc duration were estimated for each group and compared with Student's t-test. Left ventricular hypertrophy was detected in 38 of 68 patients (56%) with essential hypertension. In patients with left ventricular hypertrophy, the incidence of complex ventricular arrhythmias was two- and fivefold higher compared with patients without left ventricular hypertrophy and with controls, respectively. All of the patients with echocardiographic left ventricular dilatation had experienced complex ventricular arrhythmias. QTc duration correlated positively with left ventricular mass index and left ventricular internal diastolic dimension. The highest QTc intervals were detected in patients with left ventricular hypertrophy and complex arrhythmias. In patients with left ventricular hypertrophy, a QTc duration longer than 380 ms had a sensitivity of 74% and a specificity of 89% for detecting complex ventricular arrhythmias. It is concluded that patients with left ventricular hypertrophy have a higher incidence of complex ventricular arrhythmias and QTc prolongation in those patients can be a good marker for the increased risk of arrhythmias.

Entities:  

Mesh:

Year:  1998        PMID: 9688437     DOI: 10.1016/s0167-5273(98)00017-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure.

Authors:  Joshua M Lader; Carolina Vasquez; Li Bao; Karen Maass; Jiaxiang Qu; Eirini Kefalogianni; Glenn I Fishman; William A Coetzee; Gregory E Morley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

Review 2.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 3.  Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test?

Authors:  Steven M Stevens; Kyndaron Reinier; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02

4.  The association of serum testosterone levels and ventricular repolarization.

Authors:  Charlotte van Noord; Marcus Dörr; Miriam C J M Sturkenboom; Sabine M J M Straus; Thorsten Reffelmann; Stephan B Felix; Albert Hofman; Jan A Kors; Robin Haring; Frank H de Jong; Matthias Nauck; André G Uitterlinden; Henri Wallaschofski; Jacqueline C M Witteman; Henry Völzke; Bruno H Ch Stricker
Journal:  Eur J Epidemiol       Date:  2009-12-03       Impact factor: 8.082

Review 5.  Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?

Authors:  R Nadarajah; P A Patel; M H Tayebjee
Journal:  J Hum Hypertens       Date:  2021-03-05       Impact factor: 3.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.